List of Chapters/Sections(Table Of Content)
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nucleic Acid Multiplex Assay Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Planar Nucleic Acid Assays
1.2.3 Bead-Based Nucleic Acid Assays
1.2.4 Other Nucleic Acid Assays
1.3 Market by Application
1.3.1 Global Nucleic Acid Multiplex Assay Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Hospitals & Research Institutes
1.3.4 Reference Laboratories
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Nucleic Acid Multiplex Assay Market Perspective (2017-2028)
2.2 Nucleic Acid Multiplex Assay Growth Trends by Region
2.2.1 Nucleic Acid Multiplex Assay Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Nucleic Acid Multiplex Assay Historic Market Size by Region (2017-2022)
2.2.3 Nucleic Acid Multiplex Assay Forecasted Market Size by Region (2023-2028)
2.3 Nucleic Acid Multiplex Assay Market Dynamics
2.3.1 Nucleic Acid Multiplex Assay Industry Trends
2.3.2 Nucleic Acid Multiplex Assay Market Drivers
2.3.3 Nucleic Acid Multiplex Assay Market Challenges
2.3.4 Nucleic Acid Multiplex Assay Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nucleic Acid Multiplex Assay Players by Revenue
3.1.1 Global Top Nucleic Acid Multiplex Assay Players by Revenue (2017-2022)
3.1.2 Global Nucleic Acid Multiplex Assay Revenue Market Share by Players (2017-2022)
3.2 Global Nucleic Acid Multiplex Assay Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nucleic Acid Multiplex Assay Revenue
3.4 Global Nucleic Acid Multiplex Assay Market Concentration Ratio
3.4.1 Global Nucleic Acid Multiplex Assay Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid Multiplex Assay Revenue in 2021
3.5 Nucleic Acid Multiplex Assay Key Players Head office and Area Served
3.6 Key Players Nucleic Acid Multiplex Assay Product Solution and Service
3.7 Date of Enter into Nucleic Acid Multiplex Assay Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nucleic Acid Multiplex Assay Breakdown Data by Type
4.1 Global Nucleic Acid Multiplex Assay Historic Market Size by Type (2017-2022)
4.2 Global Nucleic Acid Multiplex Assay Forecasted Market Size by Type (2023-2028)
5 Nucleic Acid Multiplex Assay Breakdown Data by Application
5.1 Global Nucleic Acid Multiplex Assay Historic Market Size by Application (2017-2022)
5.2 Global Nucleic Acid Multiplex Assay Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Nucleic Acid Multiplex Assay Market Size (2017-2028)
6.2 North America Nucleic Acid Multiplex Assay Market Size by Country (2017-2022)
6.3 North America Nucleic Acid Multiplex Assay Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Nucleic Acid Multiplex Assay Market Size (2017-2028)
7.2 Europe Nucleic Acid Multiplex Assay Market Size by Country (2017-2022)
7.3 Europe Nucleic Acid Multiplex Assay Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nucleic Acid Multiplex Assay Market Size (2017-2028)
8.2 Asia-Pacific Nucleic Acid Multiplex Assay Market Size by Country (2017-2022)
8.3 Asia-Pacific Nucleic Acid Multiplex Assay Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Nucleic Acid Multiplex Assay Market Size (2017-2028)
9.2 Latin America Nucleic Acid Multiplex Assay Market Size by Country (2017-2022)
9.3 Latin America Nucleic Acid Multiplex Assay Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nucleic Acid Multiplex Assay Market Size (2017-2028)
10.2 Middle East & Africa Nucleic Acid Multiplex Assay Market Size by Country (2017-2022)
10.3 Middle East & Africa Nucleic Acid Multiplex Assay Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Luminex Corporation (US)
11.1.1 Luminex Corporation (US) Company Detail
11.1.2 Luminex Corporation (US) Business Overview
11.1.3 Luminex Corporation (US) Nucleic Acid Multiplex Assay Introduction
11.1.4 Luminex Corporation (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.1.5 Luminex Corporation (US) Recent Development
11.2 Thermo Fisher Scientific Inc. (US)
11.2.1 Thermo Fisher Scientific Inc. (US) Company Detail
11.2.2 Thermo Fisher Scientific Inc. (US) Business Overview
11.2.3 Thermo Fisher Scientific Inc. (US) Nucleic Acid Multiplex Assay Introduction
11.2.4 Thermo Fisher Scientific Inc. (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.2.5 Thermo Fisher Scientific Inc. (US) Recent Development
11.3 Illumina, Inc (US)
11.3.1 Illumina, Inc (US) Company Detail
11.3.2 Illumina, Inc (US) Business Overview
11.3.3 Illumina, Inc (US) Nucleic Acid Multiplex Assay Introduction
11.3.4 Illumina, Inc (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.3.5 Illumina, Inc (US) Recent Development
11.4 Bio-Rad Laboratories, Inc. (US)
11.4.1 Bio-Rad Laboratories, Inc. (US) Company Detail
11.4.2 Bio-Rad Laboratories, Inc. (US) Business Overview
11.4.3 Bio-Rad Laboratories, Inc. (US) Nucleic Acid Multiplex Assay Introduction
11.4.4 Bio-Rad Laboratories, Inc. (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.4.5 Bio-Rad Laboratories, Inc. (US) Recent Development
11.5 Qiagen N.V. (Netherlands)
11.5.1 Qiagen N.V. (Netherlands) Company Detail
11.5.2 Qiagen N.V. (Netherlands) Business Overview
11.5.3 Qiagen N.V. (Netherlands) Nucleic Acid Multiplex Assay Introduction
11.5.4 Qiagen N.V. (Netherlands) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.5.5 Qiagen N.V. (Netherlands) Recent Development
11.6 Abcam plc (UK)
11.6.1 Abcam plc (UK) Company Detail
11.6.2 Abcam plc (UK) Business Overview
11.6.3 Abcam plc (UK) Nucleic Acid Multiplex Assay Introduction
11.6.4 Abcam plc (UK) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.6.5 Abcam plc (UK) Recent Development
11.7 Becton, Dickinson and Company (US)
11.7.1 Becton, Dickinson and Company (US) Company Detail
11.7.2 Becton, Dickinson and Company (US) Business Overview
11.7.3 Becton, Dickinson and Company (US) Nucleic Acid Multiplex Assay Introduction
11.7.4 Becton, Dickinson and Company (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.7.5 Becton, Dickinson and Company (US) Recent Development
11.8 Merck KGaA (Germany)
11.8.1 Merck KGaA (Germany) Company Detail
11.8.2 Merck KGaA (Germany) Business Overview
11.8.3 Merck KGaA (Germany) Nucleic Acid Multiplex Assay Introduction
11.8.4 Merck KGaA (Germany) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.8.5 Merck KGaA (Germany) Recent Development
11.9 Agilent Technologies, Inc. (US)
11.9.1 Agilent Technologies, Inc. (US) Company Detail
11.9.2 Agilent Technologies, Inc. (US) Business Overview
11.9.3 Agilent Technologies, Inc. (US) Nucleic Acid Multiplex Assay Introduction
11.9.4 Agilent Technologies, Inc. (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.9.5 Agilent Technologies, Inc. (US) Recent Development
11.10 Meso Scale Diagnostics (US)
11.10.1 Meso Scale Diagnostics (US) Company Detail
11.10.2 Meso Scale Diagnostics (US) Business Overview
11.10.3 Meso Scale Diagnostics (US) Nucleic Acid Multiplex Assay Introduction
11.10.4 Meso Scale Diagnostics (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.10.5 Meso Scale Diagnostics (US) Recent Development
11.11 Randox Laboratories (UK)
11.11.1 Randox Laboratories (UK) Company Detail
11.11.2 Randox Laboratories (UK) Business Overview
11.11.3 Randox Laboratories (UK) Nucleic Acid Multiplex Assay Introduction
11.11.4 Randox Laboratories (UK) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.11.5 Randox Laboratories (UK) Recent Development
11.12 Quanterix (US)
11.12.1 Quanterix (US) Company Detail
11.12.2 Quanterix (US) Business Overview
11.12.3 Quanterix (US) Nucleic Acid Multiplex Assay Introduction
11.12.4 Quanterix (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.12.5 Quanterix (US) Recent Development
11.13 Bio-Techne Corporation (US)
11.13.1 Bio-Techne Corporation (US) Company Detail
11.13.2 Bio-Techne Corporation (US) Business Overview
11.13.3 Bio-Techne Corporation (US) Nucleic Acid Multiplex Assay Introduction
11.13.4 Bio-Techne Corporation (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.13.5 Bio-Techne Corporation (US) Recent Development
11.14 Olink (Sweden)
11.14.1 Olink (Sweden) Company Detail
11.14.2 Olink (Sweden) Business Overview
11.14.3 Olink (Sweden) Nucleic Acid Multiplex Assay Introduction
11.14.4 Olink (Sweden) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.14.5 Olink (Sweden) Recent Development
11.15 DiaSorin S.p.A. (Italy)
11.15.1 DiaSorin S.p.A. (Italy) Company Detail
11.15.2 DiaSorin S.p.A. (Italy) Business Overview
11.15.3 DiaSorin S.p.A. (Italy) Nucleic Acid Multiplex Assay Introduction
11.15.4 DiaSorin S.p.A. (Italy) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.15.5 DiaSorin S.p.A. (Italy) Recent Development
11.16 Seegene (South Korea)
11.16.1 Seegene (South Korea) Company Detail
11.16.2 Seegene (South Korea) Business Overview
11.16.3 Seegene (South Korea) Nucleic Acid Multiplex Assay Introduction
11.16.4 Seegene (South Korea) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.16.5 Seegene (South Korea) Recent Development
11.17 Promega Corporation (US)
11.17.1 Promega Corporation (US) Company Detail
11.17.2 Promega Corporation (US) Business Overview
11.17.3 Promega Corporation (US) Nucleic Acid Multiplex Assay Introduction
11.17.4 Promega Corporation (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.17.5 Promega Corporation (US) Recent Development
11.18 Siemens Healthineers (Germany)
11.18.1 Siemens Healthineers (Germany) Company Detail
11.18.2 Siemens Healthineers (Germany) Business Overview
11.18.3 Siemens Healthineers (Germany) Nucleic Acid Multiplex Assay Introduction
11.18.4 Siemens Healthineers (Germany) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.18.5 Siemens Healthineers (Germany) Recent Development
11.19 PerkinElmer, Inc. (US)
11.19.1 PerkinElmer, Inc. (US) Company Detail
11.19.2 PerkinElmer, Inc. (US) Business Overview
11.19.3 PerkinElmer, Inc. (US) Nucleic Acid Multiplex Assay Introduction
11.19.4 PerkinElmer, Inc. (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.19.5 PerkinElmer, Inc. (US) Recent Development
11.20 Shimadzu Biotech (Japan)
11.20.1 Shimadzu Biotech (Japan) Company Detail
11.20.2 Shimadzu Biotech (Japan) Business Overview
11.20.3 Shimadzu Biotech (Japan) Nucleic Acid Multiplex Assay Introduction
11.20.4 Shimadzu Biotech (Japan) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.20.5 Shimadzu Biotech (Japan) Recent Development
11.21 Antigenix America, Inc. (US)
11.21.1 Antigenix America, Inc. (US) Company Detail
11.21.2 Antigenix America, Inc. (US) Business Overview
11.21.3 Antigenix America, Inc. (US) Nucleic Acid Multiplex Assay Introduction
11.21.4 Antigenix America, Inc. (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.21.5 Antigenix America, Inc. (US) Recent Development
11.22 Enzo Life Sciences, Inc. (US)
11.22.1 Enzo Life Sciences, Inc. (US) Company Detail
11.22.2 Enzo Life Sciences, Inc. (US) Business Overview
11.22.3 Enzo Life Sciences, Inc. (US) Nucleic Acid Multiplex Assay Introduction
11.22.4 Enzo Life Sciences, Inc. (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.22.5 Enzo Life Sciences, Inc. (US) Recent Development
11.23 Boster Biological Technology (US)
11.23.1 Boster Biological Technology (US) Company Detail
11.23.2 Boster Biological Technology (US) Business Overview
11.23.3 Boster Biological Technology (US) Nucleic Acid Multiplex Assay Introduction
11.23.4 Boster Biological Technology (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.23.5 Boster Biological Technology (US) Recent Development
11.24 AYOXXA Biosystems GmbH (Germany)
11.24.1 AYOXXA Biosystems GmbH (Germany) Company Detail
11.24.2 AYOXXA Biosystems GmbH (Germany) Business Overview
11.24.3 AYOXXA Biosystems GmbH (Germany) Nucleic Acid Multiplex Assay Introduction
11.24.4 AYOXXA Biosystems GmbH (Germany) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.24.5 AYOXXA Biosystems GmbH (Germany) Recent Development
11.25 Cayman Chemical Company (US)
11.25.1 Cayman Chemical Company (US) Company Detail
11.25.2 Cayman Chemical Company (US) Business Overview
11.25.3 Cayman Chemical Company (US) Nucleic Acid Multiplex Assay Introduction
11.25.4 Cayman Chemical Company (US) Revenue in Nucleic Acid Multiplex Assay Business (2017-2022)
11.25.5 Cayman Chemical Company (US) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
